A significant discovery in cancer study is emerging with the use of VHH fragments to reactivate dysfunctional p53. This crucial malignant inhibitor protein is frequently lost in many types of cancer, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research